Home » Stocks » BNGO

BioNano Genomics, Inc. (BNGO)

Stock Price: $5.97 USD -0.19 (-3.08%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $5.94 -0.03 (-0.50%) Jul 23, 7:59 PM
Market Cap 1.66B
Revenue (ttm) 10.54M
Net Income (ttm) -40.54M
Shares Out 263.94M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $5.97
Previous Close $6.16
Change ($) -0.19
Change (%) -3.08%
Day's Open 6.12
Day's Range 5.88 - 6.17
Day's Volume 6,537,382
52-Week Range 0.47 - 15.69

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.

1 day ago - InvestorPlace

With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip. The post You'd Be Wrong to Paint Bionano Ge...

1 week ago - InvestorPlace

The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.

Other stocks mentioned: NVTA, OPK
1 week ago - The Motley Fool

Not all meme stocks are overvalued. These four meme stocks are good buys, as they're poised to deliver big profits for investors.

Other stocks mentioned: ARVL, BB, WISH
1 week ago - InvestorPlace

SAN DIEGO, July 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that two peer-reviewed studies from world renowned scientists and clinicians from prestigious instituti...

2 weeks ago - GlobeNewsWire

Analysts for these sought-after companies foresee upside ranging from 105% to 144% over the next year.

Other stocks mentioned: CRLBF, DKNG, KGC, SNOW
2 weeks ago - The Motley Fool

Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving -1.47% from the previous trading session.

3 weeks ago - Zacks Investment Research

SAN DIEGO, July 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Chief Medical Officer Dr. Alka Chaubey and current President of the Cancer Genomics Consortium Dr....

3 weeks ago - GlobeNewsWire

SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the 2021 Ladenburg Thalmann Healthcare Conference bei...

3 weeks ago - GlobeNewsWire

Current & Former Penny Stocks With High Marks From Analysts Right Now. The post 7 Hot Penny Stocks Analysts Like To Watch In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other stocks mentioned: AVXL, GTBP, MNKD, MOGO, QUMU, SCOR
3 weeks ago - PennyStocks

BNGO stock has established a reliable trading range. Even long-term investors can game it while they wait for their long-term reward.

3 weeks ago - InvestorPlace

Bionano Genomics (BNGO) stock is getting a boost on Monday from a couple of new pieces of news that traders will want to know. The post BNGO Stock: 2 Big Reasons Bionano Genomics Fans Should Be Cheering...

3 weeks ago - InvestorPlace

With the "story" behind it still years in the making, take your time with BNGO stock. At some point, its meme stock investors will cash out, sending it back to more reasonable prices.

3 weeks ago - InvestorPlace

Gene editing stocks are getting a boost on Monday morning after Intellia Therapeutics said it was successful using CRISPR gene-editing therapy directed inside the body to an internal organ. The post Gen...

Other stocks mentioned: CRSP, NTLA
3 weeks ago - InvestorPlace

A popular trade on social media, BNGO stock has some bullish catalysts. But the primary spark, the short squeeze, might not fire.

3 weeks ago - InvestorPlace

As Bionano's Saphyr system gains international recognition, BNGO stock deserves another chance at breaking through $15 and beyond. The post Geographic Expansion Enables Healthy Diagnosis for Bionano Gen...

4 weeks ago - InvestorPlace

In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $7.15, marking a -1.38% move from the previous day.

1 month ago - Zacks Investment Research

Solid revenue and earnings growth prospects of AMC, AHT and BNGO make them relatively safer bets despite being favorites of retail trades on the meme frenzy.

Other stocks mentioned: AHT, AMC
1 month ago - Zacks Investment Research

BNGO stock looks decent until you dive deeper and understand what's really going on. The shares' outlook isn't good.

1 month ago - InvestorPlace

Bionano Genomics offers a system called Saphyr that does optical genetic sequencing. If the technique floods the market, it could be a winner.

1 month ago - InvestorPlace

BTIG analyst Sung Ji Nam recently initiated coverage of Bionano Genomics with a buy rating and a price target of $10. Is BNGO stock a buy?

1 month ago - InvestorPlace

Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios. The post 7 A-Rated Biotech Stocks to Buy Now appeared first on Inves...

Other stocks mentioned: BNTX, CDMO, MRNA, VTGN
1 month ago - InvestorPlace

They're gaining this year. But the best may be yet to come.

Other stocks mentioned: ISRG, MRNA
1 month ago - The Motley Fool

Meme stocks have a bad rap, but categorizing them like that could prove a big and costly mistake based on what these price charts are saying The post 3 Meme Stocks to Buy Right Now! appeared first on In...

Other stocks mentioned: CLNE, GME
1 month ago - InvestorPlace

These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies. The post 5 Healthcare Stocks to Buy for Their Game-Changing Potential ap...

Other stocks mentioned: ILMN, MRNA, NVTA, SDGR
1 month ago - InvestorPlace

Does this gene-testing biotech company have value as more than a short-squeeze play?

1 month ago - The Motley Fool

The genetic testing specialist is bolstering its leadership ranks.

1 month ago - The Motley Fool

AMC stock ignites momentum in small cap penny stocks this month. The post Hot Penny Stocks To Watch As AMC Stock Ignites Small Caps In June appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: ATOS, GTBP, OCGN
1 month ago - PennyStocks

Bionano Genomics Inc. (NASDAQ: BNGO) shares climbed higher Monday after the company appointed Jason Priar as its Chief Commercial Officer. Priar was formerly a sales leader at GeneDx, Sema4, and PerkinE...

1 month ago - Benzinga

BNGO stock is gaining on Monday thanks to r/WallStreetBets interest and a new corporate higher bringing a wealth of experience. The post BNGO Stock: The Big News Lifting Bionano Genomics This Morning ap...

1 month ago - InvestorPlace

SAN DIEGO, June 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Jason Priar has joined the company as its Chief Commercial Officer. Jason is a seasoned sales lead...

1 month ago - GlobeNewsWire

Today, amid an overall red day for meme stocks, BNGO stock has soared as speculation begins to build this could be the next short squeeze. The post BNGO Stock: r/WallStreetBets Is Betting Big on a Short...

1 month ago - InvestorPlace

Demand for Bionano's Saphyr tool is climbing, while new, potentially life-saving uses are being found for it. BNGO stock remains a buy.

1 month ago - InvestorPlace

This provider of genome mapping tools is showing signs of exponential growth ahead.

1 month ago - The Motley Fool

Bionano Genomics will have to show how its products are different than the competition if BNGO stock is to hold on to its recent gains. The post The Bear Case For Bionano Genomics Carries More Weight ap...

1 month ago - InvestorPlace

SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Oppenheimer MedTech, Tools & Diagnostics Summit be...

2 months ago - GlobeNewsWire

Bionano Genomics recently reported healthy Saphyr Systems sales in the first quarter. As a result, BNGO stock gained over 20%.

2 months ago - InvestorPlace

Penny stocks remain volatile but these analysts have a bright outlook on these The post 5 Penny Stocks To Watch Right Now That Analysts Are Bullish On appeared first on Penny Stocks to Buy, Picks, News ...

Other stocks mentioned: EXPR, GTBP, MBIO, MUX
2 months ago - PennyStocks

Are these popular momentum stocks too cheap to ignore or blatant value traps?

Other stocks mentioned: MARA, NVAX, PLUG, RIOT
2 months ago - The Motley Fool

Bionano Genomics can't kick the cash-raising bug. BNGO stock could fall to $1.85, its potential cash per share if it continues to raise cash.

2 months ago - InvestorPlace

The company reported better-than-expected Q1 revenue growth.

2 months ago - The Motley Fool

Bionano Genomics, Inc. (NASDAQ: BNGO), CorMedix Inc. (NASDAQ: CRMD) and Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) are among the health care movers Friday. Bionano Moves On Q1 Results: Bionano reported ...

Other stocks mentioned: CRMD, ELOX
2 months ago - Benzinga

These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on I...

Other stocks mentioned: AIKI, ATNM, ATOS, CTIC, IMMP, ONTX
2 months ago - InvestorPlace

These penny stocks gapped up big this morning; are they worth watching? The post 3 Penny Stocks That Gapped Up Big in Early Morning Trading appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: BIOL, SNDL
2 months ago - PennyStocks

The company delivered a pleasant surprise.

2 months ago - The Motley Fool

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 0.00% and 13.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

BioNano Genomics Inc (NASDAQ:BNGO) shares traded higher by 6.9% to $4.41 after the company reported better-than-expected first-quarter sales results. Bionano Genomics reported quarterly sales of $3.2 mi...

2 months ago - Benzinga

SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the first quarter ended March 31, 2021 and highlighted re...

2 months ago - GlobeNewsWire

BioNano Genomics (NASDAQ:BNGO) is testing an important support at the $5 level. If this support breaks, shares could make a rapid and large move lower.

2 months ago - Benzinga

Don't mistake Bionano for just any Reddit stock. With its Q1 earnings looming, BNGO stock is attractively priced near its 2021 low.

2 months ago - InvestorPlace

About BNGO

Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes. Its Saphyr system includes an instrument, chip consumables, reagents, a suite of data analysis tools, and genome analysis services for researchers ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Aug 21, 2018
CEO
R. Erik Holmlin
Employees
147
Stock Exchange
NASDAQ
Ticker Symbol
BNGO
Full Company Profile

Financial Performance

In 2020, BNGO's revenue was $8.50 million, a decrease of -16.06% compared to the previous year's $10.13 million. Losses were -$41.11 million, 37.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for BNGO stock is "Buy." The 12-month stock price forecast is 11.50, which is an increase of 92.63% from the latest price.

Price Target
$11.50
(92.63% upside)
Analyst Consensus: Buy